Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Insurance
Medicare Stands Firm: No Public Coverage for New Alzheimer’s Drugs
Here’s How Your Midterms Vote Could Affect the Cost of Alzheimer’s Care
Phil’s Journal: Why Voices of Alzheimer’s? Because ‘Silence Equals Death’
How Much Does Aduhelm Cost?
More Aduhelm Drama: Packaging Could Waste Medicare Millions; Trial Tossed
CMS Says No Aduhelm Coverage for Patients Outside Clinical Trials
Op-Ed on Aduhelm and Medicare: “Don’t Limit Our Hope”
Will Medicare Cover Aduhelm? Translating the CMS’s ‘Very Confusing’ Plan
Op-Ed: Meet Voices of Alzheimer’s—And Hear Its Founders’ Take on Aduhelm
The CMS Wants Your Input on Aduhelm Coverage—Here’s How To Comment
Why Is Everyone So Mad About Aduhelm?
Aduhelm Blamed for Jump in Next Year’s Medicare Premium
Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow
Will Insurance Companies and Medicare Cover Aduhelm’s High Price Tag?
The Financial Costs of Dementia—And How to Prepare
Previous
1
2
3
Next
Page load link
Go to Top